Skip to main navigation Skip to search Skip to main content

T-cell bispecific antibodies in node-positive breast cancer: Novel therapeutic avenue for MHC class i loss variants

  • M. Messaoudene
  • , T. P. Mourikis
  • , J. Michels
  • , Y. Fu
  • , M. Bonvalet
  • , M. Lacroix-Trikki
  • , B. Routy
  • , A. Fluckiger
  • , S. Rusakiewicz
  • , M. P. Roberti
  • , S. Cotteret
  • , C. Flament
  • , V. Poirier-Colame
  • , N. Jacquelot
  • , F. Ghiringhelli
  • , A. Caignard
  • , A. M.M. Eggermont
  • , G. Kroemer
  • , A. Marabelle
  • , M. Arnedos
    • C. Vicier, S. Dogan, F. Jaulin, S. J. Sammut, W. Cope, C. Caldas, S. Delaloge, N. McGranahan, F. André, L. Zitvogel*
*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'T-cell bispecific antibodies in node-positive breast cancer: Novel therapeutic avenue for MHC class i loss variants'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology